Stockscreener 앱 받기
10.85
0.09%
-0.010
시장 영업 전:
10.89
0.04
+0.37%
전일 마감가:
$10.86
열려 있는:
$10.86
하루 거래량:
12,510
Relative Volume:
0.29
시가총액:
$209.50M
수익:
-
순이익/손실:
$6.21M
주가수익비율:
38.27
EPS:
0.2835
순현금흐름:
$-682.00K
1주 성능:
-0.09%
1개월 성능:
+0.00%
6개월 성능:
+2.94%
1년 성능:
+4.93%
1일 변동 폭
$10.84
$10.88
1주일 범위
$10.84
$10.95
52주 변동 폭
$10.34
$10.95
Translational Development Acquisition Corp Stock (TDAC) Company Profile
명칭
Translational Development Acquisition Corp
전화
(413) 204-2769
주소
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, UMAC, CCXI, DMII
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.85 | 209.69M | 0 | 6.21M | -682.00K | 0.2835 |
LION
Lionsgate Studios Corp
|
10.74 | 3.35B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.81 | 1.89B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
23.18 | 1.15B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
12.90 | 686.22M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.17 | 647.37M | 0 | 8.58M | -1.11M | 0.134 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-21 | 개시 | Northland Capital | Outperform |
Translational Development Acquisition Corp 주식(TDAC)의 최신 뉴스
ProLogium Secures $50M for TDAC Merger - iGrow News
TDACW Warrants Climb 3.77% to $1.65 as Translational Development Acquisition Corp. Holds Key SupportPut Flow Alert - dars.gov.et
TDACW Warrants Jump 13.64% to $1.50 as Support Holds FirmSpring Pattern - siam.in
Enterprise value to EBIT forward of Translational Development Acquisition Corp. – NASDAQ:TDACU - TradingView
ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors - markets.businessinsider.com
ProLogium Technology Co., Ltd. - Via Ritzau
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the MergerWEAV, BRBS, TDAC and UHG - Morningstar
Translational (TDAC) Technicals: Closes Nearly Flat at $10.85 in the Latest Session; Immediate View: Support at $10.31 and Resistance at $11.39 Frame the Range at the CloseInsider Buying Alerts - vinanet.vn
Translational (TDAC) Today: Ends a Quiet Session at $10.84 in the Latest Reading; Level Watch: the Near-Term Reference Band Stretches From $10.30 to $11.38 in the Latest ReadingCall Spread Alert - vinanet.vn
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp.TDAC - Business Wire
Translational Development Acquisition Corp. Q2 2026: Net income $947K, EPS $0.04— 10-Q Summary - TradingView
Translational Development (NASDAQ: TDAC) details ProLogium deal and $50M share subscription - Stock Titan
Translational Development Acquisition Corp. Ordinary Shares (NASDAQ: TDAC) Stock Price, News & Analysis - Kalkine
Meteora Capital (TDAC) discloses 919,000-share beneficial stake in SPAC - Stock Titan
Translational Development Acquisition (TDAC): Linden Advisors reports 6.7% ownership stake - Stock Titan
Fusemachines Inc. (FUSE) stock price, news, quote and history - Yahoo Finance Australia
Goldman Sachs Group (TDAC) discloses 1,056,879 TDAC shares in 7.2% stake - Stock Titan
Translational Development Acquisition Corp (TDAC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Translational Development Acquisition Corp. Revenue Breakdown – BOATS:TDACW - TradingView
ProLogium and Translational Development Acquisition Corp Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination - Batteries News
Translational Development Acquisition Corp (TDAC) Stock News Today - TradingKey
PNAQ.U Stock Fund Price and Chart — NYSE:PNAQ.U - TradingView
ProLogium and TDAC (NASDAQ: TDAC) gain $50M backing for battery SPAC deal - Stock Titan
Prologium, a Next Generation Solid-State Batt - Moomoo
ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment - Pulse 2.0
Translational Development Acquisition Corp. (TDAC) Edges Higher: Stability in a Quiet MarketGamma Squeeze - dars.gov.et
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment - Moomoo
ProLogium secures $50M ahead of SPAC listing at $3.8B valuation - Dealroom
ProLogium secures $50 million from existing investors By Investing.com - Investing.com Nigeria
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination - marketscreener.com
ProLogium and Translational Development Acquisition Corp. - GlobeNewswire
TDAC Announces PIPE Investment Ahead ProLogium Merger - TipRanks
Translational Development Acquisition (TDAC) lines up $50M PIPE for ProLogium merger - Stock Titan
Translational Development Acquisition Corp. Revenue Breakdown – NASDAQ:TDACW - TradingView
TDAC|Translational Development Acquisition Corp|Price:10.840|Chg%:-0.005 - TradingKey
TDAC Hovers Near Trust Value as SPAC Fluctuates Within Tight RangeChaikin Flow - vinanet.vn
Translational Development Acquisition Corp. announced that it expects to receive $50 million in funding - marketscreener.com
Translational Development Acquisition Corp. Warrants (TDACW) Surge 15.7% as Warrants Test Key ResistanceDealer Delta - dars.gov.et
TDAC|TDAC|Price:10.735|Chg%:+0.030 - TradingKey
TDACW Surges 15.7% as Warrants Trade Near Resistance — What Investors Should KnowHead and Shoulders - vinanet.vn
Price to book forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Enterprise value to EBITDA forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
TDAC Holds Steady Near Support Amid Low VolatilityVolume Oscillator - vinanet.vn
Price to sales forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Enterprise value to revenue forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Price to earnings forward of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
Wolverine Asset Management LLC Reduces Stake in Translational De - GuruFocus
Price to sales forward of Translational Development Acquisition Corp. – NASDAQ:TDACU - TradingView
TDACW Warrants Edge Higher by 0.56% as Price Nears Key Resistance LevelTriple MA Cross - vinanet.vn
Clearway Energy Reports Lower-Than-Expected Wind & Solar Generation in 2Q 2026 Due to El Niño Impacts 1 - Minichart
Wolverine Asset Management (TDAC) reports 4.89% stake in Class A shares - Stock Titan
Translational Development Acquisition Corp (TDAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.00%
자본화:
|
볼륨(24시간):